Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1656
This examiner grants 41% of resolved cases
Joseph Rankin Spangler handles cases in Tech Center 1600 and Art Unit 1656, where he has 67 resolved cases. The allowance rate of 40.3% indicates a rigorous examination process. This is paired with a median days to allowance of 1318, suggesting that reaching a grant requires both persistence and a significant time investment. The 67 resolved cases show a consistent pattern of detailed scrutiny and extended timelines.
The interview lift of 68.8% is exceptionally high, representing one of the most impactful tools available to practitioners in this docket. While the base allowance rate is only 40.3%, the 68.8% lift suggests that an interview greatly improves the likelihood of a positive outcome. For the 67 resolved cases under review, the 1318 days to allowance can be navigated more effectively through direct consultation. Practitioners should prioritize interviews early in the process to mitigate the challenges reflected in the 40.3% allowance rate. Direct communication appears to be the most successful strategy for overcoming the hurdles present in Art Unit 1656, potentially saving time and resources.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17514264 | Fibrosis Assay | Final Rejection | Georgia Tech Research Corporation |
| 17615853 | METHOD FOR ANALYZING MICROBIAL FLORA | Final Rejection | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY |
| 18032105 | WW-DOMAIN-ACTIVATED EXTRACELLULAR VESICLES | Final Rejection | President and Fellows of Harvard College |
| 18197579 | BIOANALYSIS OF THERAPEUTIC ANTIBODIES AND RELATED PRODUCTS USING IMMUNOPRECIPITATION AND NATIVE SEC-PCD-MS DETECTION | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17609841 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYHEXANEDIOIC ACID, (E)-HEX-2-ENEDIOIC ACID AND/OR HEXANEDIOIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICALS | Non-Final OA | TORAY INDUSTRIES, INC. |
| 17609964 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYHEXANEDIOIC ACID, (E)-HEX-2-ENEDIOIC ACID AND/OR HEXANEDIOIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICALS | Non-Final OA | TORAY INDUSTRIES, INC. |
| 18518641 | NOVEL DUNALIELLA SALINA AND USES THEREOF | Non-Final OA | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) |
| 17299180 | Cells with reduced inhibitor production and methods of use thereof | Final Rejection | PFIZER INC. |
| 17602367 | METHOD AND APPARATUS FOR PURIFYING BLOOD | Final Rejection | B. Braun Avitum AG |
| 18558943 | SEQUENCE-DEFINED POLYMERS WITH ONE OR MORE AZIDES, METHODS OF MAKING, AND METHODS OF USE THEREOF | Non-Final OA | Yale University |
| 17415344 | ASPARAGINASE-INDUCED GLUTAMINE DEPLETION COMBINED WITH BCL-2 INHIBITION FOR TREATMENT OF HEMATOLOGIC AND SOLID CANCERS | Final Rejection | UNIVERSITY OF MARYLAND, BALTIMORE |
| 17624764 | METHODS FOR DIAGNOSING MULTIPLE SCLEROSIS | Final Rejection | OXFORD UNIVERSITY INNOVATION LIMITED |
| 17634909 | TEXTURING L. LACTIS WITH UNIQUE EPS GENE CLUSTERS | Final Rejection | Chr. Hansen A/S |
| 16769964 | SPRAY-DRIED SIALYLLACTOSE | Final Rejection | Chr. Hansen A/S |
| 18286324 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING A POLYOLEFIN | Final Rejection | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY |
| 18287386 | REAGENT COMPOSITION AND KIT | Final Rejection | DENKA COMPANY LIMITED |
| 18720218 | NEXT GENERATION TRANSPOSOSOMES | Non-Final OA | The United States of America, as Represented by The Secretary, Department of Health and Human Servic |
| 17830227 | METHODS AND SYSTEMS FOR PREPARING THERAPEUTIC SOLUTIONS FOR POLYMICROBIAL INFECTIONS | Non-Final OA | CAP Diagnostics, LLC dba Pathnostics |
| 17418505 | BIOSYNTHETIC METHODS AND SYSTEMS FOR PRODUCING MONOSACCHARIDES | Final Rejection | Cemvita Factory, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy